Reports for LAMIVUDINE
Ingredient
LAMIVUDINE
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-ABACAVIR/LAMIVUDINE | 300MG 600MG | TABLET | Resolved | 2021-10-21 | 2021-12-17 | 147699 |
APO-LAMIVUDINE HBV | 100MG | TABLET | Resolved | 2021-05-07 | 2021-06-28 | 138957 |
AURO-LAMIVUDINE/ZIDOVUDINE | 300MG 150MG | TABLET | Resolved | 2021-05-05 | 2021-12-01 | 138774 |
APO-LAMIVUDINE | 300MG | TABLET | Resolved | 2021-02-26 | 2021-06-28 | 134757 |
APO-LAMIVUDINE HBV | 100MG | TABLET | Resolved | 2019-12-05 | 2020-02-25 | 100278 |
AURO-ABACAVIR/LAMIVUDINE | 600MG 300MG | TABLET | Resolved | 2019-09-05 | 2020-04-15 | 93077 |
APO-ABACAVIR-LAMIVUDINE | 600MG 300MG | TABLET | Resolved | 2019-08-21 | 2020-01-27 | 92016 |
TRIZIVIR | 300MG 300MG 150MG | TABLET | Resolved | 2019-08-02 | 2021-12-08 | 90619 |
MYLAN-ABACAVIR/LAMIVUDINE | 600MG 300MG | TABLET | Resolved | 2019-05-28 | 2019-06-19 | 85021 |
APO-ABACAVIR-LAMIVUDINE | 600MG 300MG | TABLET | Resolved | 2019-04-22 | 2019-07-29 | 82102 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
HEPTOVIR | 5MG | SOLUTION | To be discontinued | 2022-05-13 | 2022-05-13 | 160503 |
HEPTOVIR | 100MG | TABLET | To be discontinued | 2022-05-13 | 2022-05-13 | 160500 |
TEVA-LAMIVUDINE/ZIDOVUDINE | 300MG 150MG | TABLET | Discontinued | 2020-01-24 | 2020-01-24 | 104260 |
TRIZIVIR | 300MG 300MG 150MG | TABLET | Discontinued | 2019-09-18 | 2019-09-18 | 94278 |
APO-LAMIVUDINE HBV | 100MG | TABLET | Discontinued | 2018-09-07 | 2019-12-21 | 60563 |
APO-LAMIVUDINE | 300MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60560 |
APO-LAMIVUDINE | 150MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60557 |
Showing 1 to 7 of 7